Combating counterfeit Rx from China

July 16, 2007

Agencies worldwide are cracking down on counterfeit pharmaceuticals, and much of the focus has been on China, where an official was recently executed for approving fake medicines. While most of these drugs reach consumers through online or illegal suppliers, there’s a growing threat to outlets considered more safe, like the neighborhood pharmacy, said Temple University pharmacoeconomist, Albert Wertheimer, Ph.D., who will talk about combating counterfeit pharmaceuticals coming out of China at a U.S. Patent and Trademark Office (USPTO) seminar on July 23 and 24 in Philadelphia.

Internet pharmacies, which are extremely difficult to monitor and regulate, pose the biggest threat, but counterfeits could soon make their way into mainstream channels via sophisticated fakery and old-fashioned bribery.

“Counterfeiters have gotten very good at replicating labels and packaging,” said Wertheimer, who will focus on techniques used in other fields to identify fake goods, as well as the importance of detecting counterfeits early in the supply chain.

“Governments and industry must realize that when the danger actually becomes visible, patients may already have suffered harm,” he said.

Global efforts are underway to develop an international database that documents all counterfeit drug activity. Experts also urge greater coordination with the pharmaceutical industry.

Additionally, officials are looking at effective strategies used in other fields to fight counterfeiting including a pedigree system, which would record the path of ownership and location of a drug shipment. Each purchaser along the supply chain would add information and verify authenticity. Another technique uses sensors, inert substances that can be added to a liquid or pill, that would verify authenticity. Officials could also borrow a strategy from the retail industry – radiofrequency identification, whereby drugs would be tagged similar to clothing items.

“Still, technology cannot be a permanent, foolproof solution, and only by improving importation and regulation policy can counterfeiting be contained further. The Food and Drug Administration's Counterfeit Drug Task Force believes that attacking the problem through multiple routes will be the most effective way to combat drug counterfeiting,” Wertheimer said.

In general, counterfeit means that a drug can lack an important ingredient, contain a harmful ingredient or be mislabeled. Some of the most commonly counterfeited drugs include those for erectile dysfunction, depression, anxiety and infection. In a recent study, the World Health Organization determined global sales of counterfeit drugs to be $32 billion in 2003 – 10 percent of all medicines sold worldwide.

“Drug counterfeiting is a threat that every nation faces and the activity is very difficult to identify, trace, and combat. The growth of online drug sales, counterfeiters' increasing technologic skill, and a false sense of security in countries with stringent regulatory measures are among the factors that are enabling the spread of this criminal activity,” Wertheimer said.

U.S. and Chinese speakers at the USPTO event will be drawn from the academic and governmental fields as well as industry. Conference attendees will include businesses and companies doing or contemplating doing business with or in China, as well as those who want to protect themselves against counterfeiting and piracy from China.

Source: Temple University

Explore further: West Africa's fight to keep bad medicine off shelves

Related Stories

West Africa's fight to keep bad medicine off shelves

July 11, 2017
As West Africa declares war on the market for expired and counterfeit medicines, start-ups are putting quality control in the hands of patients to stop them risking their lives trying to get well.

Hollywood, Silicon Valley spar over online piracy bill

November 16, 2011
Hollywood sparred with Silicon Valley in the US Congress on Wednesday at a hearing on a controversial bill intended to crack down on online piracy.

Counterfeit drugs becoming big business worldwide

February 16, 2012
(AP) -- The discovery that a fake version of the widely used cancer medicine Avastin is circulating in the United States is raising new fears that the multibillion-dollar drug-counterfeiting trade is increasingly making ...

Simple new test to combat counterfeit drug problem in developing countries

August 19, 2012
In a thrust against the major problem of counterfeit medicines sold in developing countries, which causes thousands of illnesses and deaths annually, scientists today described development of a simple, paper-strip test that ...

System to catch fake drugs has idled for years

February 16, 2012
(AP) -- The news this week that a fake version of the cancer medicine Avastin has made its way into the United States highlights a longtime concern: There are few safeguards to make sure fake drugs can be spotted before ...

Pew finds serious gaps in oversight of US drug safety

July 12, 2011
Americans' medicines are increasingly manufactured in developing countries, where oversight is lower than in the U.S., according to a new white paper by the Pew Health Group. The U.S. Food and Drug Administration (FDA) estimates ...

Recommended for you

Cancer drugs' high prices not justified by cost of development, study contends

September 12, 2017
(HealthDay)— Excusing the sky-high price tags of many new cancer treatments, pharmaceutical companies often blame high research and development (R&D) costs.

Non-psychotropic cannabinoids show promise for pain relief

September 4, 2017
Some cancers love bone. They thrive in its nutrient-rich environment while gnawing away at the very substrate that sustains them, all the while releasing inflammatory substances that cause pain—pain so severe that opioids ...

Fentanyl drives rise in opioid-linked deaths in U.S.

August 31, 2017
(HealthDay)—Fentanyl, a synthetic narcotic, is a key player in America's continuing epidemic of opioid-related overdose deaths, two new studies report.

Eating triggers endorphin release in the brain

August 28, 2017
Finnish researchers have revealed how eating stimulates brain's endogenous opioid system to signal pleasure and satiety.

Cholesterol-lowering drugs may fight infectious disease

August 21, 2017
That statin you've been taking to lower your risk of heart attack or stroke may one day pull double duty, providing protection against a whole host of infectious diseases, including typhoid fever, chlamydia, and malaria.

Data revealed under FOI shows benefits of multiple sclerosis drug currently blocked by regulators

August 17, 2017
A drug that is blocked by the EU regulatory system has now been found to improve the quality of life of people with multiple sclerosis (MS), according to a study by Queen Mary University of London (QMUL).

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.